Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Patnaik

Showing results (11-20 of 34) with videos related to

Pageof 4
Sort By:
Indian Heart Journal|March 3, 1999
Radiofrequency catheter ablation of common atrial flutter--acute and follow-up resultsB H Rao, M Nair, J C Mohan, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 5, 2018
A phase I dose-escalation and dose-expansion study of brontictuzumab in subjects with selected solid tumorsR Ferrarotto, G Eckhardt, A Patnaik, et al.
Kidney International|January 1, 1996
Antikaliuretic action of trimethoprim is minimized by raising urine pHM Schreiber, L E Schlanger, C B Chen, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 28, 2009
Phase I and pharmacokinetic study of lexatumumab (HGS-ETR2) given every 2 weeks in patients with advanced solid tumorsH A Wakelee, A Patnaik, B I Sikic, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 10, 2015
A phase I, first in human study of FP-1039 (GSK3052230), a novel FGF ligand trap, in patients with advanced solid tumorsA W Tolcher, K P Papadopoulos, A Patnaik, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 31, 2000
Phase I dose-finding and pharmacokinetic study of paclitaxel and carboplatin with oral valspodar in patients with advanced solid tumorsA Patnaik, E Warner, M Michael, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 3, 2005
A phase I, pharmacokinetic and biologic correlative study of oblimersen sodium (Genasense, G3139) and irinotecan in patients with metastatic colorectal cancerM M Mita, L Ochoa, E K Rowinsky, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 26, 2001
A phase I and pharmacological study of the farnesyl protein transferase inhibitor L-778,123 in patients with solid malignanciesC D Britten, E K Rowinsky, S Soignet, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 2, 2001
Phase I and pharmacokinetic study of NSC 655649, a rebeccamycin analog with topoisomerase inhibitory propertiesA W Tolcher, S G Eckhardt, J Kuhn, et al.
British Journal of Cancer|June 6, 2014
Phase I ficlatuzumab monotherapy or with erlotinib for refractory advanced solid tumours and multiple myelomaA Patnaik, G J Weiss, K P Papadopoulos, et al.
Pageof 4

Showing results (11-20 of 34) with videos related to

Sort By:
Pageof 4
Indian Heart Journal|March 3, 1999
Radiofrequency catheter ablation of common atrial flutter--acute and follow-up resultsB H Rao, M Nair, J C Mohan, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 5, 2018
A phase I dose-escalation and dose-expansion study of brontictuzumab in subjects with selected solid tumorsR Ferrarotto, G Eckhardt, A Patnaik, et al.
Kidney International|January 1, 1996
Antikaliuretic action of trimethoprim is minimized by raising urine pHM Schreiber, L E Schlanger, C B Chen, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 28, 2009
Phase I and pharmacokinetic study of lexatumumab (HGS-ETR2) given every 2 weeks in patients with advanced solid tumorsH A Wakelee, A Patnaik, B I Sikic, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 10, 2015
A phase I, first in human study of FP-1039 (GSK3052230), a novel FGF ligand trap, in patients with advanced solid tumorsA W Tolcher, K P Papadopoulos, A Patnaik, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 31, 2000
Phase I dose-finding and pharmacokinetic study of paclitaxel and carboplatin with oral valspodar in patients with advanced solid tumorsA Patnaik, E Warner, M Michael, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 3, 2005
A phase I, pharmacokinetic and biologic correlative study of oblimersen sodium (Genasense, G3139) and irinotecan in patients with metastatic colorectal cancerM M Mita, L Ochoa, E K Rowinsky, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 26, 2001
A phase I and pharmacological study of the farnesyl protein transferase inhibitor L-778,123 in patients with solid malignanciesC D Britten, E K Rowinsky, S Soignet, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 2, 2001
Phase I and pharmacokinetic study of NSC 655649, a rebeccamycin analog with topoisomerase inhibitory propertiesA W Tolcher, S G Eckhardt, J Kuhn, et al.
British Journal of Cancer|June 6, 2014
Phase I ficlatuzumab monotherapy or with erlotinib for refractory advanced solid tumours and multiple myelomaA Patnaik, G J Weiss, K P Papadopoulos, et al.
Pageof 4